Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Uveal Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02678572
What this trial is testing

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Who this might be right for
Ocular MelanomaUveal Melanoma
Delcath Systems Inc. 102
Testing effectiveness (Phase 2)Ended earlyNCT01801358
What this trial is testing

A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Array Biopharma, now a wholly owned subsidiary of Pfizer 38
Early research (Phase 1)Looking for participantsNCT04855435
What this trial is testing

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorUveal Melanoma, MetastaticCutaneous Melanoma
MonTa Biosciences ApS 106
Testing effectiveness (Phase 2)UnknownNCT02913417
What this trial is testing

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Who this might be right for
Uveal MelanomaHepatic Metastases
David Minor, MD 26
Testing effectiveness (Phase 2)Study completedNCT00288041
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586
What this trial is testing

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 210
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00058279
What this trial is testing

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT01217398
What this trial is testing

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
Institut Curie 35
Testing effectiveness (Phase 2)Study completedNCT03472586
What this trial is testing

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)UnknownNCT00168870
What this trial is testing

Study of Metastatic Ocular Melanoma

Who this might be right for
Ocular Melanoma
Charite University, Berlin, Germany 48
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)UnknownNCT05077280
What this trial is testing

Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
California Pacific Medical Center Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT01585194
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
M.D. Anderson Cancer Center 67
Early research (Phase 1)Active Not RecruitingNCT05496686
What this trial is testing

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaMetastatic
Modulation Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01034787
What this trial is testing

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
AHS Cancer Control Alberta 11
Early research (Phase 1)Study completedNCT00471471
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Intraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)
Ahmad Tarhini 22
Testing effectiveness (Phase 2)Study completedNCT00084656
What this trial is testing

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Bristol-Myers Squibb 77
Next Page